Edgemoor Investment Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Edgemoor Investment Advisors's BIIB Position: Q3 2019 in Review
Edgemoor Investment Advisors sold out of Biogen (BIIB) in Q3 2019, closing a stake of 1,100 shares — an estimated $257K sold.
Edgemoor Investment Advisors first reported a position in BIIB in Q2 2013 and held it in 21 quarters. The position peaked at $365K in Q1 2015. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.
- Edgemoor Investment Advisors reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
- Edgemoor Investment Advisors sold 1,100 Biogen shares in Q3 2019, an estimated $257K.
- Edgemoor Investment Advisors first reported a position in Biogen in Q2 2013 and held it in 21 quarters.
- Edgemoor Investment Advisors's Biogen position peaked at $365K in Q1 2015.
- 989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.
Based on Edgemoor Investment Advisors's 13F filing for Q3 2019, filed 6 Nov 2019.